Radcliffe Cardiology
Radcliffe Cardiology
Radcliffe Cardiology
Radcliffe Cardiology
Radcliffe Cardiology
Radcliffe Cardiology
Radcliffe Cardiology
Radcliffe Cardiology
Radcliffe Cardiology
AHA 2026 Highlights: Key Trials in Heart Failure and Cardiovascular Risk
AHA 2026 Highlights: Key Trials in Heart Failure and Cardiovascular Risk AHA 2026 - Dr Amanda Vest (Cleveland Clinic, US) ...
Dr Alasnag on TRANSFORM II: Is "Leave Nothing Behind" the Future of PCI? #interventionalcardiology
Dr Alasnag on TRANSFORM II: Is "Leave Nothing Behind" the Future of PCI? #interventionalcardiology Visit Radcliffe Cardio ...
TCT 26: 3 Trials That Will Change My Practice with Dr Mirvat Alasnag
TCT 26: 3 Trials That Will Change My Practice with Dr Mirvat Alasnag Which TCT 2026 trials could influence cardiovascular ...
Rethinking Representation in Cardiovascular Trials | Keith Ferdinand #AHA2026 #cardiology #news
Rethinking Representation in Cardiovascular Trials | Keith Ferdinand #AHA2026 #cardiology #news Visit Radcliffe Cardiolog ...
AHA 2026: RACE-CARS | Bystander CPR Improved, What Can We Learn About Survival? #cardiology #news
AHA 2026: RACE-CARS | Bystander CPR Improved, What Can We Learn About Survival? #cardiology #news Visit Radcliffe Cardiol ...
AHA 2026: Revisiting LDL-C, ApoB & Lp(a) in the 2026 Dyslipidemia Guidelines #cardiology
AHA 2026: Revisiting LDL-C, ApoB & Lp(a) in the 2026 Dyslipidemia Guidelines #cardiology Visit Radcliffe Cardiology: http ...
AHA 2026: Can #ai Plaque Quantification Change #CAD Management? | PARAMOUNT #cardiology #aha2026
AHA 2026: Can #ai Plaque Quantification Change #CAD Management? | PARAMOUNT #cardiology #aha2026 [Description] Visit Radc ...
#aha 2026: OCEANIC-STROKE Across #Cardiovascular Risk Groups #cardiology
#aha 2026: OCEANIC-STROKE Across #Cardiovascular Risk Groups #cardiology Visit Radcliffe Cardiology: https://www.radcli ...
AHA 2026: ZEUS: Ziltivekimab and Cardiovascular Outcomes
AHA 2026: ZEUS: Ziltivekimab and Cardiovascular Outcomes ZEUS at AHA 2026 examines inflammation as a therapeutic target i ...
AHA 2026: OPTIMAL-DIABETES & OPTIMAL-STROKE
AHA 2026: OPTIMAL-DIABETES & OPTIMAL-STROKE New AHA 2026 data puts systolic blood pressure targets in focus. In this late ...
01-27-2021
11-30-2020
11-20-2020
11-17-2020
10-27-2020
10-08-2020
10-07-2020
09-30-2020
09-09-2020
09-09-2020
08-13-2020
06-30-2020
06-08-2020
06-06-2020
05-21-2020
Get notified about new releases.
Sign up for email updates from Radcliffe Group Ltd.